
US FDA Staff Expresses Concerns Over Merck’s Chronic Cough Drug Efficacy
November 17, 2023
Ahead of an upcoming meeting of independent experts, the U.S. health regulator’s staff has raised doubts about the adequacy of data supporting Merck’s chronic cough drug’s meaningful benefits, according to documents released on Wednesday. Merck’s shares dropped nearly 1 percent








